Issuer name: Observe Medical ASA

Ex. date: 14 January 2025

Type of corporate action: Reverse share split

Other information: Fifteen (15) old shares will give one (1) new share. After
the reverse share split, the share capital is NOK 75,107,806.80 divided into
19,258,412 shares, each with a nominal value of NOK 3.90. The shares in Observe
Medical ASA will be traded with new ISIN from today, 14 January 2025.

New ISIN after reverse share split: NO0013457952.

This information is published in accordance with the requirements of the
Continuing Obligations for companies listed on the Oslo Stock Exchange and
Euronext Expand.

For further information, please contact:

Jørgen Mann, CEO Observe Medical

Mobile: +45 408 67 558

E-mail: jorgen.mann@observemedical.com

Johan Fagerli, CFO Observe Medical

Mobile: +47 958 12 765

E-mail: johan.fagerli@observemedical.com

About Observe Medical:

Observe Medical is a Nordic medtech company that develops, markets and sells
innovative medtech products for the global market. The Company is committed to
improving patient welfare and patient outcomes, improving clinical data accuracy
and promoting positive health economics.

The Company seeks to drive growth by leveraging its expertise in sales and
commercialisation of its broad portfolio of medical technology products, mainly
in urine measurement and ultrasound, in combination with targeted M&A and
distribution. Observe Medical is working with a network of leading distributors
to provide outstanding solutions for healthcare professionals globally.

The Company is headquartered in Oslo, Norway.

Further information is available at www.observemedical.com.